These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 942484)

  • 21. Activity of some mixed function oxidases in prenatally carbon disulphide (CS2) treated rats.
    Nikiforov B; Tabacova S
    Arch Toxicol Suppl; 1980; 4():296-8. PubMed ID: 6933920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hexachlorophene, tribromsalan, trichlorcarban and cloflucarban on hexobarbital sleeping time and hepatic drug-metabolizing enzyme activity in vitro in the rat.
    Condie LW; Buhler DR
    Biochem Pharmacol; 1979; 28(3):375-80. PubMed ID: 426854
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatic microsomal mixed-function oxidase system in rats pretreated with cicloxilic acid.
    Casini AF; Comporti M; Subissi A; Murmann W
    Arzneimittelforschung; 1978; 28(7a):1218-20. PubMed ID: 582958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of adrenalectomy on hepatic mixed function oxidase activity in female rats.
    Fry JR; Wilson CG
    J Pharm Pharmacol; 1983 Jan; 35(1):52-3. PubMed ID: 6131968
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of reduced barometric pressure on drug action and metabolism in mice.
    Hawkins SF; Hankinson JB; Merritt JH; Medina MA
    Biochem Pharmacol; 1971 Sep; 20(9):2221-9. PubMed ID: 5163139
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro effects of Phenoclor DP6 on drug metabolism in rat liver.
    Narbonne JF
    Bull Environ Contam Toxicol; 1979 Oct; 23(3):344-8. PubMed ID: 117859
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity.
    Park BK
    Br J Clin Pharmacol; 1981 Aug; 12(2):97-102. PubMed ID: 7030374
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of pregnancy on the metabolism of drugs in the rat and rabbit.
    Neale MG; Parke DV
    Biochem Pharmacol; 1973 Jun; 22(12):1451-61. PubMed ID: 4738892
    [No Abstract]   [Full Text] [Related]  

  • 29. [Liver and metabolism of drugs].
    Darnis F
    Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug disposition in spontaneously hypertensive rats.
    Ben-Zvi Z; Kaplanski J; Warszawski D
    Pharmacol Res Commun; 1980 Oct; 12(9):873-6. PubMed ID: 7443767
    [No Abstract]   [Full Text] [Related]  

  • 31. Hexobarbital sleeping time and drug metabolism in rats with ligated bile ducts--a lack of correlation.
    Drew R; Priestly BG
    Biochem Pharmacol; 1976 Jul; 25(14):1659-63. PubMed ID: 942466
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of parenteral dimethyl sulfoxide (DMSO) on drug metabolizing enzyme activities in the phenobarbital pretreated rat.
    Willson RA; Hart FE
    Biochem Pharmacol; 1977 May; 26(9):902-3. PubMed ID: 861058
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic drug metabolism after phenobarbital and diphenylhydantoin administration in the rat--influence of vitamin D3 status.
    Gascon-Barré M; Côte MG; Brodeur J
    Biochem Pharmacol; 1979; 28(2):313-9. PubMed ID: 218591
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of capsaicinoids with drug-metabolizing systems. Relationship to toxicity.
    Miller MS; Brendel K; Burks TF; Sipes IG
    Biochem Pharmacol; 1983 Feb; 32(3):547-51. PubMed ID: 6847703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced development of tolerance to pentobarbital by desipramine inhibition of pentobarbital metabolism.
    Liu SJ; Wang RI
    Biochem Pharmacol; 1976 Oct; 25(19):2211-4. PubMed ID: 971334
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of levels of feed restriction on in vivo and in vitro alterations in drug metabolism and associated enzymes.
    Sachan DS; Su PK
    Drug Nutr Interact; 1986; 4(4):363-70. PubMed ID: 3792217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglutethimide as an inducer of oxidative drug metabolism in the rat.
    Damanhouri Z; Herbert SA; Nicholls PJ
    Pharmacol Ther; 1987; 33(1):145-52. PubMed ID: 2442781
    [No Abstract]   [Full Text] [Related]  

  • 38. Selectivity of cholestyramine treatment on hepatic mixed function oxidase activity.
    Bachmann K; Schwartz J; Forney R; Sherman G; Jauregui L
    Pharmacology; 1984; 29(3):128-41. PubMed ID: 6483959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.
    Farquhar D; Loo TL; Gutterman JU; Hersh EM; Luna MA
    Biochem Pharmacol; 1976 Jul; 25(13):1529-35. PubMed ID: 782458
    [No Abstract]   [Full Text] [Related]  

  • 40. Ascorbic acid and drug metabolism.
    Zannoni VG; Flynn EJ; Lynch M
    Biochem Pharmacol; 1972 May; 21(10):1377-92. PubMed ID: 4402218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.